Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yasuhiko Shiki
A Phase I/Ii Study of GLIF Combination Chemotherapy for Taxane/Platinum-Refractory/Resistant Endometrial Cancer (GOGO-EM2)
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Related publications
A Phase II Study of Gemcitabine Monotherapy in Breast Cancer Patients Refractory to Anthracycline and Taxane
Cancer Research and Treatment
Cancer Research
Oncology
A Phase II Study of the Combination Chemotherapy of Bevacizumab and Gemcitabine in Women With Platinum-Resistant Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Journal of Ovarian Research
Gynecology
Oncology
Obstetrics
Emerging Role for Bevacizumab in Combination With Chemotherapy for Patients With Platinum-Resistant Ovarian Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Phase I/Ii Studies of Combination Chemotherapy With S-1 and Platinum in Patients With Previously Untreated Metastatic or Recurrent Gastric Cancer
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
A Phase II Trial of Prostate-Specific Membrane Antigen Antibody Drug Conjugate (PSMA ADC) in Taxane-Refractory Metastatic Castration-Resistant Prostate Cancer (mCRPC).
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Prm212 - Patient Experience With Platinum-Resistant or Platinum-Refractory Ovarian Cancer
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Randomized Phase II Study of the PDGFRα Antibody Olaratumab Plus Liposomal Doxorubicin Versus Liposomal Doxorubicin Alone in Patients With Platinum-Refractory or Platinum-Resistant Advanced Ovarian Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
A Phase II Trial of Docetaxel and Ifosfamide for Patients With Platinum-Resistant or Refractory Non-Small Cell Lung Cancer in a Salvage Setting
Cancer Research and Treatment
Cancer Research
Oncology
A Phase I Study of Niclosamide in Combination With Enzalutamide in Men With Castration-Resistant Prostate Cancer
PLoS ONE
Multidisciplinary
